Application

19308662 · TOPICAL SKIN FORMULATIONS OF A PHARMACEUTICALLY ACCEPTABLE SALT OF RUXOLITINIB

Filed 2025-08-25 · Pending The official file ↗ · Art unit 1619 · Examiner John P Nguyen Typical · CPC A61K 9/107 · INCYTE CORPORATION · Finnegan/Incyte Corporation

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

2.6 mo

to disposition n/a

Statutes raised

103

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.